When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CAPR - Capricor up 26% premarket on continuation of DMD study
Capricor Therapeutics Inc.
Nano cap Capricor Therapeutics (NASDAQ:CAPR) is up 26% premarket on light volume in response to its announcement that the independent Data and Safety Monitoring Board has completed its safety and futility analyses of its Phase 2 HOPE-2 clinical trial evaluating lead candidate CAP-1002 in boys and young men with advanced stages of Duchenne muscular dystrophy (DMD) and has recommended that the study continue.
More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move,